643 Acta Chim. Slov. 2010, 57, 643-650 Scientific paper Synthesis, Spectroscopic, Spectrophotometric and Crystallographic Investigations of 4-{[(1E)-(3,4-dimet-hoxyphenyl)methylene]amino}-1,5-dimethyl-2-phenyl-1,2-dihydro-3#-pyrazol-3-one and 4-{[(1E)-(2-hydroxy-5-met-hoxyphenyl)methylene]amino}-1,5-dimethyl-2-phenyl-1,2- dihydro-3#-pyrazol-3-one Zeliha Hayvali,1'* Huseyin Unver2 and Ingrid Svoboda3 1 Ankara University, Faculty of Science, Department of Chemistry, TR-06100 Tandogan, Ankara, Turkey 2 Ankara University, Faculty of Science, Department of Physics, TR-06100 Tandogan, Ankara, Turkey 3 Institute for Materials Science, Darmstadt University of Technology, Petersenstrasse 23, D-64287 Darmstadt, Germany * Corresponding author: E-mail: zhayvali@science.ankara.edu.tr; Tel: +90-312-2126720 Received: 07-07-2009 Abstract Two new Schiff base ligands 4-{[(1£)-(3,4-dimethoxyphenyl)methylene]amino}-1,5-dimethyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one (1) and 4-{[(1£)-(2-hydroxy-5-methoxyphenyl)methylene]amino}-1,5-dimethyl-2-phenyl-1,2-dihy-dro-3H-pyrazol-3-one (2) have been prepared and characterized using elemental analysis, UV-vis, FT-IR, 1H and 13C NMR spectroscopy, and X-ray crystallographic technique. Tautomeric equilibria (phenol-imine, O-H'N and keto-ami-ne, O'H-N forms) have been studied by using UV-vis absorption spectra for the compound 2 in some solutions. Crystal structure analyses showed that the title molecules 1 and 2 crystallize in the monoclinic space group P21/c and P21 with the unit cell parameters: a = 12.5665(3) A and 5.6666(2) A; b = 10.4791(2) A and 12.2444(5) A; c = 14.6240(3) A and 12.1556(4) A; V = 1820.65(7) A3 and 826.84(5) A3; Dx = 1.282 g.cm-3 and 1.355 g.cm-3; and Z = 4 and 2, respectively. Keywords: Schiff base, spectroscopic studies, crystal structure, tautomerism, hydrogen bonding l.Introduction Schiff base ligands are the basis of an extensive class of transition and main group elements in coordination chemistry.1-4 The Schiff bases of 4-aminoantipyrine have attracted the attention of the researchers5'6 because of their biological7-9 and analytical10 activities. 4-aminoan-tipyrine derivatives and their metal complexes have been investigated for bioactivity and analgetic,11 antimicrobial12 and anticancer activity.13 New kinds of chemo-the-rapeutic antitumor agents containing Schiff bases have increased significant attention among biochemists,14 and of those aminoantipyrine derivatives are commonly mana- ged intravenously to detect liver disease15 in clinical treatment. Both in solution and the solid state, tautomerism in Schiff base derivatives of o-hydroxyaldehydes have been investigated using IR,1(U7 UV,18-20 1H NMR,21,22 and X-ray crystallographic techniques.23,24 The UV-vis spectra of some Schiff base derivatives of o-hydroxyaldehydes have been studied in both polar and nonpolar solvents.25 A new band at higher wavelenghts than 400 nm has been observed in polar solvent and in acidic media. However, this band has not been observed in some nonpolar solvents. The results indicate that the absorption band at higher wa-velenghts (>400 nm) belongs to the keto-amine form of Hayvali et al.: Synthesis, Spectroscopic, Spectrophotometric and Crystallographic Investigations 644 _Acta Chim. Slov. 2010, 57, 643-650 the Schiff base. In Schiff bases derived from salicylal-dehyde, the keto-amine form was not observed in both polar and non-polar solvents, but it was observed with the acid addition.26 In this study, we have synthesized title compounds (Scheme 1) and investigated their molecular structures by using UV-vis, FT-IR, 1H and 13C NMR spectroscopic methods. UV-vis spectra of the compound 2 have been recorded in different solvents, and in basic (NEt3) and acidic (CF3COOH) media. Phenol-imine and keto-amine form for compound 2 have been assigned from these spectra. We have also determined crystal structures of 1 and 2 by using X-ray crystallographic technique. H,C—O 7 - \ IOV--N 12 13 H / \ 5 6N0H H3C CH3 13 13 Scheme 1. Chemical structures of the title compounds 1 and 2. 2. Experimental 2. 1. Reagents and Techniques Melting points were measured on a Thomas-Hoover apparatus using a capillary tube. 1H and 13C NMR spectra were obtained on a Bruker DPX FT-NMR (400 MHz) spectrometer with SiMe4 as an internal standard. IR spectra were obtained from a PEL-DATA spectrum 100 series spectrometer. Elemental analyses were performed on a LECO CHNS-932 analyzer. 4-aminoantipyrine and 2-hy-droxy-5-methoxybenzaldehyde were purchased from Al-drich, and 3,4-dimethoxybenzaldehyde was prepared according to the literature method.27 UV-vis spectra were obtained using a UNICAM UV2-100 series spectrometer. 2. 2. Synthesis of the Title Compound 1 4-Aminoantipyrine (0.68 g, 3.37 mmol) was dissolved in ethanol (50 mL) and the solution was added drop-wise to the solution of 3,4-dimethoxybenzaldehyde (0.56 g, 3.37 mmol) in ethanol (50 mL). The mixture was reflu-xed for 1h and then allowed to come to ambient temperature. Bright yellow crystals were formed in ethanol and recrystallized in acetone. Fine yellow crystals obtained upon slow evaporation at room temperature were characterized, including single crystal X-ray diffraction. Yield, 0.91 g (77%); mp: 183 C. Anal. Calc. for C20H21N3O3: C, 68.38; H, 5.98; N, 11.97. Found: C, 68.76; H, 6.18; N, 12.23%. IR (v, cm1) 1647 (C=O), 1573 (C=N), 1510 (C=C), 1259 (C-O-C). 1H NMR (CDCl3, 5, ppm): 2.39 [(C-CH3(20)), s, 3H], 3.02 [(N-CH3(19) ), s, 3H], 3.89 [(OCH3(17)), s, 3H], 3.83 [(OCH3(18)), s, 3H], 9.66 [(N=CH(7)), s, 1H], 6.83 [(H(3)), d, 1H, /=8.15 Hz], 7.22 [(H(14 5)X m, 2H], 7.24-7.39 [(H^W, m, 4H], 7.51 [(H(1)), s, 1H]. 13C NMR (CDCl3', 5, ppm): 124.19 (C(1612)), 129.08 (C(1513)), 126.70 (C^), 149.20 (C^)), 131.17 (C(10)), 134.85 (C(8)), 160. (C(9)), 156.76 (C(7)), 118.71 (C(6)), 108.41 (C(1)), 151.08 (C(2)), 151.57 (C(3)), 110.74 (C(4)), 122.83 (C^), 10.09 (C^), 35.85 (C^p, 55.85 (C(17)), 55.80 (CnS)). (18/ 2. 3. Synthesis of the Title Compound 2 The above synthetic procedure was repeated for 2 by using 2-hydroxy-5-methoxybenzaldehyde. Yield, 0.83 g (74%); mp: 166 C. Anal. Calc. for C19H19N3O3: C, 67.66; H, 5.64; N, 12.46. Found: C, 67.63; H, 5.71; N, 12.59%. IR (v, cm1) 1652 (C=O), 1574 (C=N), 1498 (C=C), 1264 (C-O-C). 1H NMR (CDCl3, 5, ppm): 2.37 [(C-CH3(19)), s, 3H], 3.14 [(N-CH3(18)), s, 3H], 3.74 [(OCH3(17)), s, 3H], 9.79 [(N=CH(7)), s, 1H], 6.88 [(H(4)), s, 1H], 6.(86 [(H(5)), s, 1H], 7.28-7.(52 [^1615141312)), m, 5H], 7.52 [(H(2)), s, 1H], 12.84 [(OH), s, 1H]. 1H NMR (CDCl3+CF3COOH, 5, ppm): 2.44 [(C-CH3(19)), s, 3H], 3.27 [(N-CH3(18) ), s, 3H], 3.78 [(OCH3(17)), s, 3H], 9.65 [(N-CH(7)), d, 1H], 9.88 [(N=CH(7)), s, 1H], 6.89-7.56 [(H s^^^O, m, 8H], 12.82 [(OH), bs, 1H], 15.98 [(HN-C), d, 1H]. 13C NMR (CDCl3, 5, ppm): 124.65 (C(1612)), 129.28 (C(1513)), 124.65 (C(14)), 134.34 (Cai), 119.94 (C^)), 127.30 (C^), 154.64 (C(9)), 160.13 (C(7)), 116.17 (C(1)), 115.00 (C(2)), 149.87 (C(3)), 119.12 (C(4)), 117.44 (C(1)), 152.29 (C^), (4) 10.18 (C(19)), 35.55 (C(18)), 55.82 (C^.^C NMR (CDC- (6) l3+CF3COOH, 5, ppm): 159.95-112.30 (C (C(19)), 36.05 (C(1S)), 57.38 (C^). (1-5, 7-16)- ), 10.01 (18) (17) 2. 4. The Determination of X-ray Structures X-ray data were collected on an Oxford Diffraction Xcalibur (TM) Single Crystal X-ray Diffractometer28 with MoKa radiation using œ/28 scan mode low-temperature facilities. All non-hydrogen atoms were refined with ani-sotropic thermal displacement parameters. The positions of H atoms were calculated, and were refined. The structures were solved by SHELXS-9729 and refined with SHELXL-97.30 The details of the X-ray data collection, structure solution and structure refinements are given in Table 1. Bond distances and angles are listed in Table 2. The molecular structures with the atom-numbering scheme for compound 1 and 2 are shown in Figures 1 and 2,31 1 2 Hayvali et al.: Synthesis, Spectroscopic, Spectrophotometric and Crystallographic Investigations 645 Acta Chim. Slov. 2010, 57, 643-650 respectively. Crystallographic data (excluding structure factors) for the structures reported in this present paper have been deposited in the Cambridge Crystallographic Data Centre as supplementary publication no. CCDC 728285 and 728521.32 Table 1. Crystal data and structure refinements for the title compounds. Table 2. Some selected bond lengths (A) and bond angles (°) for the title compounds. Compound 1 2 Empirical Formula C20 H21 N3 O3 C19 H19 N3 O3 Formula weight 351.40 337.37 Crystal system Monoclinic Monoclinic Space group P21/c p 21 Crystal size 0.36 x 0.36 0.50 x 0.50 x x 0.16 mm3 0.50 mm3 Unit cell a = 12.5665(3) Ä a = 5.6666(2)Ä dimensions b = 10.4791(2)Ä, b = 12.2444(5)Ä, ß= 109.018(3)° ß= 101.376(4)° c = 14.6240(3) c = 12.1556(4) V 1820.65(7) Ä3 826.84(5)Ä3 Z 4 2 Dc 1.282 g cm-3 1.355 g cm-3 ^(MoKa) 0.088 mm-1 0.094 mm-1 F(000) 744 356 26 max 52.74 ° 52.74 ° h, k, l range -15 < h < 15 -7 < h < 6 -12 < k < 13 -15 < k < 14 -18< l < 18 -14< l < 15 Reflections collected 3721 5336 Reflections observed 2545 1759 (I>2o(I)) Refinement method Full-matrix Full-matrix least- least-squares on F2 squares on F2 Data / restraints 2545/1/298 1759/1/284 / parameters Goodness-of-fit on F2 1.095 1.113 Final R indices R1 = 0.0368, R1 = 0.0256, [I>2o(I)j wR2 = 0.0916 w1R2 = 0.0642 R indices (all data) R1 = 0.0643, R1 =2 0.0298, wR2 = 0.1192 w1R2 = 0.0668 Largest diff. 0.2421 and 0.119 and peak and hole -0.250 e.Ä-3 -0.173 e.Ä-3 Compound 1 C(2)-C(3) 1.417(2) C(3)-O(2) 1.364(2) C(7)-N(1) 1.288(2) C(8)-C(10) 1.372(2) C(8)-N(1) 1.392(2) C(8)-C(9) 1.449(2) C(11)-N(2) 1.422(2) C(12)-C(13) 1.379(2) C(19)-N(3) 1.467(2) N(2)-N(3) 1.408(2) C(7)... O(3) 3.0383 O(1)-C(2)-C(3) 114.9(1) C(1)-C(2)-C(3) 120.0(1) O(3)-C(9)-N(2) 124.0(1) O(3)-C(9)-C(8) 131.2(1) N(2)-C(9)-C(8) 104.8(1) C(8)-C(10)-N(3) 110.3(1) C(7)-N(1)-C(8) 120.9(1) C(9)-N(2)-N(3) 110.0(1) N(2)-N(3)-C(19) 116.1(1) C(2)-O(1)-C(17) 116.6(1) Compound 2 C(6)-O(2) 1.359(2) C(7)-N(1) 1.288(2) C(8)-C(10) 1.374(2) C(8)-N(1) 1.393(3) C(8)-C(9) 1.445(3) C(9)-O(3) 1.233(2) C(10)-C(19) 1.483(2) C(11)-C(16) 1.382(3) C(17)-O(1) 1.432(2) C(18)-N(3) 1.465(3) O(2)...N(1) 2.6177(2) O(1)-C(3)-C(2) 124.3(2) O(1)-C(3)-C(4) 116.2(2) C(4)-C(5)-C(6) 120.5(2) O(2)-C(6)-C(5) 118.8(2) N(1)-C(7)-C(1) 120.8(2) C(10)-C(8)-N(1) 122.6(2) O(3)-C(9)-N(2) 123.3(2) O(3)-C(9)-C(8) 131.4(2) N(3)-N(2)-C(11) 115.9(1) C(9)-N(2)-C(11) 119.6(1) C(10)-N(3)-N(2) 108.3(1) C(10)-N(3)-C(18) 123.6(1) Figure 1. ORTEP-3 drawing31 of the compound 1 with displacement ellipsoids plotted at 50% probability level; the intramolecular hydrogen bond has been indicated by dashed lines. Figure 2. ORTEP-3 drawing31 of the compound 2 with displacement ellipsoids plotted at 50% probability level; intramolecular hydrogen bonds have been represented by dashed lines. 3. Results and Discussion 3. 1. Spectroscopic Investigation Direct reaction of one equivalent of 4-aminoantip-yrine with one equivalent of appropriate aldehyde in etha-nol gives the corresponding Schiff base. Compounds 1 and 2 were isolated as yellow crystalls with 77 and 74% yield, respectively. They were characterized by elemental analysis, UV-vis, IR, 1H and 13C NMR spectroscopic techniques. The characteristic infrared spectra were given in the Experimental section. The IR spectra of 1 and 2 show Hayvali et al.: Synthesis, Spectroscopic, Spectrophotometric and Crystallographic Investigations 646 Acta Chim. Slov. 2010, 57, 643-650 strong bands at 1573 and 1574 cm-1, characteristic for the imine bond and assigned to the azomethine C=N groups. The sharp peaks in the range between 1647 and 1652 cm-1 can be attributed to the vC=O stretching modes for 1 and 2, respectively. The phenolic OH stretching band was not observed, indicating the formation of a cyclic intramolecular hydrogen bond. The 1H NMR spectra of the Schiff bases show characteristic singlets at 9.66 and 9.79 ppm, respectively, corresponding to the azomethine HC=N proton. The aliphatic C-CH3 and N-CH3 protons were observed as singlets at 2.39 and 3.02 ppm for compound 1 and at 2.37 and 3.14 ppm for compound 2. The aromatic protons for compound 1 and 2 appear as multiplets in the range 6.83-7.50 ppm and 6.86-7.52 ppm, respectively. Protons for two met-hoxy protons in compound 1 were observed at 3.83 and 3.89 ppm, and protons for one methoxy group in compound 2 were detected at 3.74 ppm. The OH proton for compound 2 was observed as a singlet at 12.84 ppm. The UV-vis spectra of Schiff base 1 was measured in DMSO, EtOH and CHCl3. Two absorption bands were observed for compound 1 at 240-280 and at 336-348 nm due to the n-n* transition. UV-vis absorption bands for compounds 1 and 2 in various solvents are presented in Table 3. As one may expect, tautomerism is not possible for compound 1, thus CF3COOH and NEt3 show no effects in UV-vis spectra (Table 3). Figures 3 and 4 show the representative UV-vis spectra of compound 2 in different solvents and in acidic media. The UV-vis spectral behaviour of Schiff bases have been extensively investigated in recent years.33-35 Tautomerism in Schiff base derivatives of o-hydroxyaldehydes in solution and in solid state have been investigated using mass spectra,36 NMR,37 UV-vis38-42 and X-ray crystallography.42,43 The plausible existence of tautomerism in solution (phenol-imine and keto-amine forms, O-H"N ^ O^H-N), depending on the formation of intramolecular hydrogen bonding is shown in Scheme 2. Solvent polarity affects the phenol-imine and keto-amine tautomeric equlibria in Schiff bases by stabilizing the more polar keto-amine form, although frequently no clear-cut relation between phenol-imine/keto-amine ratio and solvent polarity could be established.35 In the spectra of compound 2, n-n* and intramolecular charge transfer interaction bands44 are observed at 238-282 and 328-372 nm in DMSO, EtOH, CHCl3 and toluene, respectively. The charge transfer interaction bands originate from 4-aminoantipyrine ring and belongs to the C=N group.44 The UV-vis spectra for 2 in neutral and basic media (NE-t3) showed that the phenol-imine form is dominant. In basic media, the keto-amine (O...H-N) / phenol-imine (O-H...N) ratios were approximately the same as in the respective pure solvent media of compound 2. However, in acidic media (CF3COOH) of CHCl3 and toluene a new bands at 440 nm and 438 nm have been observed, respec-tively.26 These bands can be linked with the shift of the tautomeric equilibrium to the keto-amine form. The results in acidic solution indicates that methoxy salicylaldi-mine 2 gives salt with CF3COOH.45 The absence of keto-amine form in the acidic DMSO and EtOH solutions may be explained by the hydrogen bonding to acid (CF3COOH).43,46 After the addition of CF3COOH in CDCl3 the tau-tomerism for compound 2 was also studied by 1H and 13C NMR spectroscopy (see Experimental section). The 1H NMR data for compound 2 in CDCl3 showed the existence of only phenol-imine tautomer, while both phe-nol-imine and keto-amine forms have been observed in acidic CDCl3. In acidic CDCl3 the 1H NMR spectra for compound 2 the OH absorption was observed as a broad singlet at 12.82 ppm, because of CF3COOH addition. However, in pure CDCl3 as solvent, this absorption was observed as a sharp singlet at 12.84 ppm. N=CH proton was observed as a singlet at 9.88 ppm while N-CH proton was observed as a doublet at 9.65 ppm. The hydrox-yl proton (O-H...N) and amine proton (O...H-N) were observed at 12.82 and 15.98 ppm, respectively. The new peaks (for HN-CH and HN-CH) showed that the keto-amine tautomer was present in acidic CDCl3. Because of two tautomeric forms the 1H NMR spectrum of aromatic region became much more complex in acidic medium. The relative ratios of phenol-imine/keto-amine tauto-mers were estimated to be 49/51% from the spectra of compound 2. In the 13C NMR spectra of acidic CDCl3 solution of 2 a lot of additional carbon peaks were observed compared to the 13C NMR spectra in pure CDCl3 as solvent. It can be concluded from UV-vis and nMr spectra that the keto-amine/phenol-imine tautomeric forms were present in the acidic solution of compound 2 in CDCl3. Phenol-imine Scheme 2. The expected phenol-imine/keto-amine tautomeric equilibria for compound 2. Keto-amine Hayvali et al.: Synthesis, Spectroscopic, Spectrophotometric and Crystallographic Investigations 647 Acta Chim. Slov. 2010, 57, 643-650 Table 3. UV-vis spectral data for 1 and 2. Comp. Solvents x, nm (log e) Keto-amine isomer (%)a,b ic,d DMSO 280 (4.34); 348 (4.56) dmso+cf3cooh 282 (4.23); 344 (4.50) - DMSO+NEtj 280 (4.12); 348 (4.55) EtOH 240 (4.40); 338 (4.56) EtOH+CF3COOH 238 (4.39); 336 (4.35) - EtOH+NEt3 240 (4.28); 336 (4.54) CHCl3 240 (4.36); 340 (4.58) CHCl3+CF3COOH 242 ( 4.24); 336 (3.95) - CHCl3+NEt3 240 ( 4.28); 336 (4.02) 2 DMSO 282 (4.31); 338 (4.41); 370 (4.55) 0.0 dmso+cf3cooh 284 (4.19); 340 (4.28); 370 (4.42) 0.0 DMSO+NEt3 282 (4.38); 336 (4.41); 370 (4.55) 0.0 EtOH 238 (4.41); 316 (4.26); 328 (4.26); 368 (4.31) 0.0 EtOH+CF3COOH 238 (4.30); 318 (3.72); 328 (4.14); 366 (4.18) 0.0 EtOH+NEt3 240 (4.22); 316 (4.28); 328 (4.27); 368 (4.31) 0.0 CHCl3 244 (4.48); 318 (4.36); 330 (4.36); 368 (4.39) 0.0 CHCl3+CF3COOH 244 ( 4.63); 332 (4.24); 360 (4.31); 440 (4.36) 52.4 CHCl3+NEt3 244 (4.44); 316 (4.38); 330 (4.36); 370 (4.39) 0.0 Toluene 282 (4.36); 320 (4.47); 328 (4.47); 372 (4.49) 0.0 Toluene+CF3COOH 284 (4.38); 318 (4.40); 366 ( 4.44); 438 (4.45) 50.8 Toluene+NEt3 284 (4.22); 320 (4.48); 334 (4.47); 376 (4.49) 0.0 a A2/A1=x(100-x) where Aj= the absorbance of the phenol-imine form; Aj= the absorbance of the keto-amine form; x= the percentage of keto-amine form. b Basic/acidic medium is attained by addition of NEt3/CF3COOH (1 mL) to the given solution (ligand concentration: 5 X 10-5 mol dm-3). c Not sufficiently soluble in Toluene. d Tautomerism is impossible for compound 1, the mark (-) is used. 2,0 300 400 500 nm Figure 3. UV-vis spectra showing solvent effect on compound 2 in DMSO (-□-), chloroform (-A-), ethanol (-+-), and toluene ( ); concentration 5 X 10-5 mol dm-3. 2.0 1.5 300 400 500 nm Figure 4. UV-vis spectra showing acidic effect on compound 2 in DMSO (-□-), chloroform (-A-), ethanol (-+-), and toluene (); concentration 5 x 10-5 mol dm-3. 3. 2. Crystallographic Study Schiff base compounds have a variety of substi-tuents with different electron-donating and electron-withdrawing groups, and therefore may have interesting electro-chemical properties of great interest for molecular electronic devices. They have been under intense investigation in previous years because of their potential applicability in optical communications and many of them have Non Linear Optic (NLO) behavior.47 Second-order NLO organic materials that contain stable molecules with large Hayvali et al.: Synthesis, Spectroscopic, Spectrophotometric and Crystallographic Investigations 648 Acta Chim. Slov. 2010, 57, 643-650 molecular hyperpolarizabilities in noncentrosymmetric packing are of great interest for device applications, but according to a statistical study, an overwhelming majority of a chiral molecules crystallize centrosymmetrically. Compounds 1 and 2 (see Figures 1 and 2) can be described as comprising of central part of C=N bridging 3,4-dimethoxybenzaldehyde and 2-hydroxy-5-methoxy-benzaldehyde and 4-amino-1,2-dihydro-1,5-dimethyl-2-phenyl-3H-pyrazole-3-one aniline fragments. Selected bond lengths and angles from the X-ray analysis are presented in Tables 1 and 2, respectively. Determined bond lengths and angles within the aromatic rings are consistent with those expected for sp2 aromatic carbon atoms. Bond lengths between C6-C7 [1.463(2) Á] in compound 1 and between C1-C7 [1.454(3) Á] in compound 2 are consistent with single bonds between sp2-hybridized carbon atoms. For the imine nitrogen atoms, N1 and N2, the bond angles C8-N1-C7 [121.0(2)°] for 1 and C8-N1-C7 [121.4(2)°] for 2 confirm their sp2 character. In compound 1 are one nonclassical intramolecular hydrogen bond and three intermolecular hydrogen bonds. There are two intramolecular hydrogen bonds and one intermolecular hydrogen bond in compound 2. The crystal structures are stabilized by intramolecular and intermolecular hydrogen bonding and their geometrical details are listed in Table 4.4849 Weak intramolecular hydrogen bonds occur between C7-H7...O3 [3.0383(3) Á] atoms in compound 1, and between O2-H2A...N1 [2.6177(2) Á] and C7-H7...O3 [3.0300(2) Á] atoms in compound 2 (see Figures 1 and 2). The sum of the Van der Waals radius of the O and N atoms (3.07 Á) is significantly longer than the intramolecular O...N hydrogen bond length.50 There are also weak intermolecular hydrogen bonds between C4...O3 [3.4239(2) Á], C13...O3 [3.2787(2) Á], and C20...O3 [3.3080(2) Á] for the compound 1 (see Figure 5) and between C18...O1 [3.3316(1) Á] atoms of neighbouring molecules for the compund 2. Table 4. Geometric details of intramolecular and intermolecular hydrogen bonding for the title compounds.3 [D - H...A] [D - H] [H...A] [D...A] [D - H...A] (Â_ (Â) (À) (À) (°) Compound 1 C7-H7... O3 C4-H4... O31 C13-H13. ..O311 C20-H20A...O3111 Compound 2 O2-H2A...N1 0.87 1.81 2.6177 154 C7-H7...O3 1.01 2.36 3.0300 123 C18-H18B...O11v 0.96 2.44 3.3316 154 a D: donor, A: acceptor. Symmetry transformation used to generate equivalent atoms: (i) 1-x, -y, 1-z; (ii) x, 1/2-y, -1/2+z; (iii) 1-x, 1/2+y, 1/2-z; (iv) 1+x, -1+y, z Figure 5. The crystal structure of the compound 1 a perspective view. The intramolecular and intermolecular hydrogen bonds have been indicated by dashed lines. C-N group in compound 2 seems to have a strong electron withdrawing character. Thus, the C6-O2 bond distance of 1.356(2) À is also consistent with the C-O single bonding; similarly the C7=N1 distance of 1.288(2) À is also consistent with the C=N double bonding. The C=O bond distance indicates the presence of the keto form, with a partial double bond character of the CO group (>C=O o C+-O). The Csp3-O-Csp3 bond lengths vary because of the influence of tautomerism. Furthermore, the ^C_N torsion angles C6-C7-N1-C8 [176.25(13)°] for compound 1 and C1-C7-N1-C8 [-172.49(17)°] for compound 2 show that the configurations around the C7=N1 bond are in accordance with the phenol-imine tautomeric form (Scheme 2). 4. Conclusions We have prepared a new type of ligands from 4-ami-noantipyrine with 3,4-dimethoxybenzaldehyde and 2-hy-droxy-5-methoxybenzaldehyde. They were characterized by using elemental analysis, FT-IR, 1H and 13C NMR spectroscopic techniques. The position of the tautomeric equilibrium for compound 2 was investigated by using UV-vis spectrophotometry. In order to determine the tautomeric form and molecular structure of the compound 2 in the solid state, we used X-ray crystallographic technique. Based on the crystallographic results, we can conclude that the title compounds were in the phenol-imine tautomeric form. 5. Acknowledgement The authors gratefully acknowledge the financial support of the Scientific and Technical Research Council 0.98 2.37 0.96 2.54 1.01 2.44 1.01 2.55 3.0383 125 3.4239 154 3.2787 140 3.3080 131 Hayvali et al.: Synthesis, Spectroscopic, Spectrophotometric and Crystallographic Investigations 649 Acta Chim. Slov. 2010, 57, 643-650 of Turkey (TUBITAK, Grant number TBAG 109T034) and Ankara University Research Fund (Grant number 20020705070). 6. References 1. W. L. Liu, Y. Zou, C. L. Ni, Y. Z. Li, Q. J. Meng, J. Mol. Struct., 2005, 751, 1-6. 2. P. Przybylski, G. Schroder, B. Brzezinski, J. Mol. Struct., 2003, 658, 115-124. 3. R. Dreos, G. Nardin, L. Randaccio, P. Siega, G. Tauzher, V. Vrdoljak, Inorg. Chim. Acta, 2003, 349, 239-248. 4. M. T. H. Tarafder, K. B. Chew, K. A. Crouse, A. M. Ali, B. M. Yamin, H. K. Fun, Polyhedron, 2002, 21, 26832690. 5. Z. Hayvali, M. Hayvali, Z. Kilic, T. Hokelek, J. Mol. Struct., 2001, 597, 223-234. 6. T. Hokelek, Z. Kilic, Z. Hayvali, Anal. Sci., 2002, 18, 495496. 7. K. Z. Ismail, Transition Metal Chemistry, 2000, 25, 522528. 8. J. Hosler, C. Tschanz, C. E. Hignite, D. L. Azarnoff, J. Invest. Dermatol., 1979, 74, 51-53. 9. S. Chandra, D. Jain, A.K. Sharma, P. Sharma, Molecules, 2009, 14, 174-190. 10. N. T. Madhu, P. K. Radhakrishnan, M. Grunert, P. Weinberger, W. Linert, Thermochim. Acta, 2003, 400, 29-36. 11. V. C. Filho, R. Correa, Z. Vaz, J. B. Calixto, R. J. Nunes, T. R. Pinheiro, A. D. Andricopulo, R. A. Yunes, IL Farmaco, 1998, 53, 55-57. 12. N Raman, A. Kulandaisamy, A. Shunmugasundaram, Transition Metal Chemistry, 2001, 26, 131-135. 13. N. Raman, J. Dhaveethu Raja, A. Sakthivel, J. Chem. Sci., 2007, 119, 303-310. 14. K. Bernardo, S. Leppard, A. Robert, G. Commenges, F. De-han, B. Meunier, Inorg. Chem., 1996, 35, 387-396. 15. D. Chiaramonte, J. M. Steiner, J. D. Broussard, K. Baer, S. Gumminger, E. M. Moeller, D. A. Williams, R. Shumway, Can. J. Vet. Res., 2003, 67, 183-188. 16. J. W. Ledbetter, Jr. J. Phys. Chem, 1977, 81, 54-59. 17. J. Lewis, W. C. Sandorfy, Can. J. Chem., 1982, 60, 17271737. 18. B. J. Tardiff, J. C, Smith, S. J. Duffy, C. M. Vogels, A. D. Stephen, Can. J. Chem. 2007, 85, 392-399. 19. Jr. J. W. Ledbetter, J. Phys. Chem, 1966, 70, 2245-2249. 20. Jr. J.W. Ledbetter J. Phys. Chem., 1967, 71, 2351-2354. 21. G. O. Dudek, R.H. Holm, J. Am. Chem. Soc., 1962, 84, 2691-2696. 22. G. C. Perey, D.A. Thornton, J. Inorg. Nucl. Chem., 1972, 34, 3357-3367. 23. D. E. Hamilton, R.S. Drago, A. Zombeck, J. Am. Chem. Soc., 1987, 109, 374-379. 24. D. Chen, A. E. Martel, Inorg. Chem. 1987, 26, 1026-1030. 25. H. Nazir, M. Yildiz, H. Yilmaz, M. N. Tahir, D. Ulku, J. Mol. Struct., 2000, 524, 241-250. 26. S. R. Salman, S. H. Shawkat, G. A. Al-Obaidi, Canadian J. of Spectroscopy, 1990, 35, 25-27. 27. J. S. Buck, Organic Syntheses, Coll. Vol., 1943, 2, 619-620. 28. Oxford Diffraction CrysAlis CCD and CrysAlis RED. Version 1. 170. 14. Oxford Diffraction, Oxfordshire, England, 2002. 29. G. M. Sheldrick, SHELXS-97, Program for the solution of Crystal Structure, Univ. of Goettingen, Germany, 1997. 30. G. M. Sheldrick, SHELXL-97, Program for the refinement of Crystal Structures, Univ. of Goettingen, Germany, 1997. 31. L. J. Farrugia, J. Appl. Crystallogr, 1997, 30, 565-566. 32. Further information may be obtained from: Cambridge Cry-stallographic Data Center (CCDC), 12 Union Road, Cambridge CB21EZ, UK, by quoting the depository numbers CCDC- 231864 and 231866 E-mail: depositccdc.cam.ac.uk. 33. Z. Hayvali, D. Yardimci, Transition Met. Chem., 2008, 33, 421-429. 34. D. Heinert, A. Martel, J. Am. Chem. Soc., 1963, 85, 183188. 35. W. M. F. Fabian, L. Antonov, D. Nedeltcheva, F. S. Kamou-nah, P. J. Taylor, J. Phys. Chem., 2004, 108, 7603-7612. 36. S. R. Salman, R. D. Farrant, J. C. Lindon, Spect. Lett., 1991, 1071-1078. 37. Z. Rozwadowski, W. Schilf, B. Kamienski, Magn. Reson. Chem., 2005, 45, 573-577. 38. M Hayvali, Z. Hayvali, Synth. React. Inorg. Met. Org. Chem., 2004, 34, 713-732. 39. Z. Hayvali, N. Gunduz, Z. Kilic, E. Weber, Z. Naturforsch, 2000, 55b, 975-981. 40. Z. Hayvali, M. Hayvali, Z. Kilic, T. Hokelek, E. Weber, J. Incl. Phenom. Macrocycl. Chem., 2003, 45, 285-294. 41. H. Unver, E. Kendi, K. Guven, T. N. Durlu, Z Naturforsch, 2002, 57b, 685-690. 42. H. Unver, M. Yildiz, N. Ocak, T. N. Durlu, J. Chem. Crystal-logr, 2008, 38, 103-108. 43. M. Yildiz, H. Unver, D. Erdener, N. Ocak, A. Erdonmez, T. N. Durlu, Cryst. Res. Technol, 2006, 41, 600-606. 44. R. M. Issa, A. M. Khedr, H. F. Rizk, Spectrochimica Acta Part A, 2005, 62, 621-629. 45. S. Bilge, Z. Kilic, Z. Hayvali, T. Hokelek, S. Safran, J. Chem. Sci., 2009, 121, 989-1001. 46. M. Yildiz, Z. Kilic, T. Hokelek, J. Mol. struct., 1998, 441, 1-10. 47. M. Jalali-Heravi, A. A. Khandar, I. Sheikshoaie, Spectrochim Acta Part A, 1999, 55, 2537-2544. 48. G-Y Yeap, S-T. Ha, N. Ishizawa, K. Suda, P-L. Boey, W. Mahmood, J. Mol. Struct, 2003, 658, 87-99. 49. G. Y. Yeap, S. G. Teoh, S. B. Teo, S. C. Loh, H. K. Fun, Polyhedron, 1996, 15, 3941-3946. 50. A. Bondi, J. Phys. Chem., 1964, 68, 441-451. Hayvali et al.: Synthesis, Spectroscopic, Spectrophotometric and Crystallographic Investigations 650 Acta Chim. Slov. 2010, 57, 643-650 Povzetek Avtorji v prispevku poročajo o pripravi dveh novih Schiffovih baz kot ligandov; 4-{[(1_E)-(3,4-dimetoksifenil)meti-len]amino}-1,5-dimetil-2-fenil-1,2-dihidro-3_ff-pirazol-3-ona (1) in 4-{[(1_E)-(2-hidroksi-5-metoksifenil)metilen]ami-no}-1,5-dimetil-2-fenil-1,2-dihidro-3_ff-pirazol-3-ona (2). Obe spojini sta okarakterizirani z elementno analizo, UV-vis, FT-IR, 1H in C NMR spektroskopijami ter z rentgensko kristalografsko analizo. Za nekatere raztopine spojine 2 je bilo s pomočjo UV-vis absorpcijske spektroskopije študirano ravnotežje med fenol-imin (O-H'N) in keto-amin (O'N-H) tavtomerno obliko. Kristalografska analiza je pokazala, da obe spojini (1 in 2) kristalizirata v monoklinski prostorski skupini P2/c in P21 s sledečimi parametri celice: a = 12.5665(3) A in 5.6666(2) A; b = 10.4791(2) A in 12.2444(5) A; c = 14.6240(3) A in 12.1556(4) A; V=1820.65(7) A3 in 826.84(5) A3; Dx = 1.282 g.cm-3 in 1.355 g.cm-3; Z = 4 in 2. Hayvali et al.: Synthesis, Spectroscopic, Spectrophotometric and Crystallographic Investigations